Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by palinc2000on Apr 15, 2021 4:43pm
82 Views
Post# 33005255

RE:RE:RE:The problem

RE:RE:RE:The problemI dont know why  the weakest link  in the C suite still has a job,,,One has to  be hard pressed not to see the depth of management in all aspects of the business except except in ONE aspect ,,,,,I
Does Paul have his hands tied or is he too solf ? It has to be one or the other


scarlet1967 wrote: Unfortunately although there have been so many great suggestions on this MB not many have been directly communicating their ideas with the company. In a sense what is going on here is very similar to what has been going on at the company which is a lot of talking but not much action.
After been emailing Leah multiple times per month for more than a year sharing yours and my suggestions with no obvious changes I requested to talk to her although she seemed to agree with me on many issues and assured me there will be many surprising changes in the following months here we are again a lot of talking but no action.
I certainly hope all the time consuming great works by posters here get communicated by the same posters with the company. The effect of many active shareholders interaction with the company is much better than only one or two.


<< Previous
Bullboard Posts
Next >>